Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin

Heidi V. Russell, Douglas Strother, Zhuyong Mei, Donna Rill, Edwina Popek, Ettore Biagi, Eric Yvon, Malcolm Brenner, Raphael Rousseau

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin'. Together they form a unique fingerprint.

Medicine & Life Sciences